Startseite>>Signaling Pathways>> Others>> Organ- & System-Specific Toxicity>>Allethrin

Allethrin (Synonyms: NSC 11782, RU 27436)

Katalog-Nr.GC40476

Allethrin, ein Pyrethroid-Insektizid, ist ein wichtiges MÜckenschutzmittel. Allethrin induziert oxidativen Stress, Apoptose und Calciumfreisetzung in Hodenkarzinomzellen der Ratte (LC540). Allethrin induziert BCL-2, Caspase-3-Aktivierung und Freisetzung von intrazellulÄrem Calcium.

Products are for research use only. Not for human use. We do not sell to patients.

Allethrin Chemische Struktur

Cas No.: 584-79-2

Größe Preis Lagerbestand Menge
50mg
43,00 $
Auf Lager
100mg
82,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Allethrin is a pyrethroid insecticide and modulator of voltage-gated sodium channels (NaV). It delays channel deactivation in cockroach giant axons when used at a concentration of 1 μM. Allethrin is 100-fold more potent at insect than rat NaV1.8 channels expressed in Xenopus oocytes. It decreases egg production by and is lethal to mosquitoes (LC50 = 0.01%). Allethrin induces production of reactive oxygen species (ROS), lipid peroxidation, and apoptosis in rat primary Leydig cells. In vivo, the smoke of an allethrin-based mosquito coil increases levels of the hepatic enzymes ALT and AST and induces hepatocyte apoptosis as well as emphysema and lung hyperplasia in mice.

Bewertungen

Review for Allethrin

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Allethrin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.